These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1324788)

  • 1. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers.
    Zhang L; Nakaya K; Yoshida T; Kuroiwa Y
    Cancer Res; 1992 Sep; 52(17):4634-41. PubMed ID: 1324788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells.
    Jing Y; Watabe M; Hashimoto S; Nakajo S; Nakaya K
    Anticancer Res; 1994; 14(3A):1193-8. PubMed ID: 8074471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells.
    Zhang LS; Nakaya K; Yoshida T; Kuroiwa Y
    Biochem Biophys Res Commun; 1991 Jul; 178(2):686-93. PubMed ID: 1859424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
    Nakamaki T; Kawakami K; Sato S; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
    Anticancer Res; 1992; 12(5):1331-7. PubMed ID: 1444189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin.
    Numazawa S; Shinoki MA; Ito H; Yoshida T; Kuroiwa Y
    J Cell Physiol; 1994 Jul; 160(1):113-20. PubMed ID: 8021291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.
    Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.
    Onozaki K; Akiyama Y; Okano A; Hirano T; Kishimoto T; Hashimoto T; Yoshizawa K; Taniyama T
    Cancer Res; 1989 Jul; 49(13):3602-7. PubMed ID: 2786454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and differentiation in HL-60 leukemia cells induced by 1,25-dihydroxyvitamin D3 and tumor necrosis factor alpha.
    Wang SY; Chen LY; Wang SJ; Lin CK; Ho CK
    Exp Hematol; 1991 Nov; 19(10):1025-30. PubMed ID: 1915703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q; DeFrances MC; Zarnegar R
    Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
    Legdeur MC; Bontje PM; Ossenkoppele GJ; Beelen RH; van de Loosdrecht AA; Broekhoven MG; Langenhuijsen MM; Thijsen SF; Hofstee H; Schuurhuis GJ
    Exp Hematol; 1996 Nov; 24(13):1530-9. PubMed ID: 8950237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.
    Testa U; Masciulli R; Tritarelli E; Pustorino R; Mariani G; Martucci R; Barberi T; Camagna A; Valtieri M; Peschle C
    J Immunol; 1993 Mar; 150(6):2418-30. PubMed ID: 8383719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.